Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2032

Conditions
Nasopharyngeal Cancinoma (NPC)
Interventions
RADIATION

Radiation Therapy

PTVnx:70Gy/33Fr;PTVnd:70Gy/33Fr;PTV1:60Gy/33Fr;PTV2:42Gy/26Fr.

RADIATION

Radiation Therapy

PTVnx:70Gy/33Fr;PTVnd:70Gy/33Fr;PTV1:60Gy/33Fr;PTV2:54Gy/33Fr.

Trial Locations (1)

510060

Sun yat-sen university cancer center, Guangzhou

All Listed Sponsors
collaborator

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

OTHER

collaborator

First Affiliated Hospital of Guangxi Medical University

OTHER

collaborator

Affiliated Hospital of Guangdong Medical University

OTHER

collaborator

The University of Hong Kong-Shenzhen Hospital

OTHER

collaborator

Dongguan People's Hospital

OTHER_GOV

collaborator

Affiliated Cancer Hospital of Shantou University Medical College

OTHER

lead

Sun Yat-sen University

OTHER